TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: ATPmax production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Voice signature identification for fatigue differentiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Teamwork Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Teamwork Skill Use
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Social Climate Perception
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Efficacy of propranolol in boosting immunotherapy effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Area under the plasma concentration-time curve (AUC0-infinity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional connectivity measured by fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Response accuracy to psychological tasks
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Difference in traditional biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in proteomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in metabolomics/lipidomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in global cerebral glucose metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Motor strength in quadriceps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Short term impact on mood as assessed by the Positive and Negative Emotions Scale (PANAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Short term impact on anxiety as assessed by the General Anxiety Disorder-7 (GAD-7) scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sum of pain relief scores over 6 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of intraocular pressure after upper cervical manipulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of intraocular pressure after sphenopalatine ganglion manipulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child's daily participation performance and satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Parent-child interaction strategy utilization
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Child's social communication ability
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Creatine Kinase Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breathlessness measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of acute exacerbation of participants
Endpoint domain: Adverse events/effects
Primary endpoint: Change in vertigo severity rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay in obtaining fibrinogen results
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Velocity-time integral
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ACT (or ACQ) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sensitivity of the RBCs-based blood test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the RBCs-based blood test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive predictive value (PPV) of the RBCs-based blood test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative predictive value (NPV) of the RBCs-based blood test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of time spent in extreme saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Radiographic vertical bone changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of body parts with work-related musculoskeletal systems (WRMSs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Assessment of early LV systolic dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Dyspepsia Severity Scale symptom ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of parsaclisib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC 0-∞ of parsaclisib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-t) of parsaclisib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Th-17 cytokine secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of patients admitted to the emergency department
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: External ventricular drain (EVD) occlusion test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Radiation dosimetry and biodistribution of [18F]PBR111
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of lisinopril in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of lisinopril in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse device effects by 12 months post-surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Fusion status at last assessment by 12 months post-surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: SVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of re-infection
Endpoint domain: Adverse events/effects
Primary endpoint: Muscle ATP concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse events after CAR-T cells infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Objective response rate after CAR-T cells infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in V O2 max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in peak VO2 %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Refractive Error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of days gambled in the last month
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: knee valgus angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee internal rotation angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee valgus torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee extension torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Upper Extremity Skills Test (QUEST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder X-ray results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of cleft palate without cleft lip
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of Serious Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Adverse events meeting protocol defined dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of short term treatment side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Growth pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose (MTD) of CC-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended phase-II dose of CC-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative hypertensive event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in CDR-SB (Clinical Dementia Rating-Sum of Boxes)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Composite Endpoint of Clinical Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technical feasibility
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: percentage of emergency room admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in skin surface temperature at the local stimulated area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in skin surface temperature at the knee area on both sides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Blood glucose differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean change from baseline in BCVA at 24 week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in BCVA at 52 week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline subcutaneous abdominal adipose tissue glycerol concentration at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline gluteal adipose tissue glycerol concentration at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline whole-body lipolysis at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of non-revascularization treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: NET activation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PAD4 Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Headache Pain Freedom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of concurrent adjuvant immunotherapy and radiation therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Impulsive Behavior Scale Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Eating attitudes Test (EAT-26)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Balloon analogue risk task (BART)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Per cent weight change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion losing at least 5% body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in VOCs peaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oxygen partial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: response-related clinical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma progesterone level on the day of embryo transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: HCV antibody prevalence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: IOP changes from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and frequency of adverse events (AE) and serious adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Device Feasibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sentinel lymph node detection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sentinel lymph node technique accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Functional independence as measured by SCIM-SR
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Suicide Prevention Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Youth Connectedness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Rate of patients without a treating doctor
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Bone mineral density change of lumbar spine (L1-L4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Hemodynamic modifications of the cardiac cavities after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ventilatory regimes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Weekly alcohol consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage change in mean score of self-kindness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage change in mean score of self-valuation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Stage of Change
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Physician Burnout
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants Reporting Cytokine Release Syndrome (CRS) Cases by Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Time to First Episode of Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Confirmed Protocol Defined ILI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: RNA expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medial joint space width
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of Acute Procedural Success (APS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of freedom from Major Adverse Event (MAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Score on the Jong Gierveld Loneliness Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of participants diagnosed with microbiologically confirmed TB and started on TB treatment within 72 hours
Endpoint domain: Adverse events/effects
Primary endpoint: Increased nicotine delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Craving/withdrawal suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calibration of Prospera test for heart injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Worries about Labour
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Defect Bone Level (DBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IOP from medicated baseline at 12 months post-MIMS® surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in the number of topical IOP-lowering medications from medicated baseline at 12 months post-MIMS® surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Success rate at 12 months post-MIMS® surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bleeding volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasmatic syndecan -1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of post-spinal hemodynamic instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in high contrast visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper Limb Motor Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross Manual Dexterity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of gynecological emergency room visits for non-urgent reasons
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Modified Oswestry Low Back Pain Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quebec back pain disability scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Site of the meatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of hemoptysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quantity of hemoptysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in AIS motor score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of urinary retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Phrenic nerve compound muscle action potential (CMAP) amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Phrenic nerve compound muscle action potential (CMAP) duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Phrenic nerve compound muscle action potential (CMAP) area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Low Back Activity Confidence Scale (Lobacs)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Oswestry Back Pain Disability Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Quebec back pain disability scale (QBPDS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Enrollment of >= 70% of eligible participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: >= 70% of enrolled participants who answer the telephone calls from City of Hope interventionists
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence/engagement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence of Abemaciclib induced diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of any local and systemic AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with presence (and severity) of local skin reactions (LSRs)
Endpoint domain: Adverse events/effects
Primary endpoint: variation of number of involuntary facial spasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Decrease in parasite load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Plasma Concentration of Rilpivirine (RPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration of Cabotegravir (CAB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in systolic blood pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy of Rifaximin in preventing SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Postoperative opioid usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Functional Assessment of Cancer Therapy general scale: FACT-G V4
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Progress-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Drug re-use rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Drug retreatment response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Visual Performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety of Osimertinib 80mg/eod
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of stimulant overdose
Endpoint domain: Adverse events/effects
Primary endpoint: Correct assessment of high nutrients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived healthfulness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Selection of a product high in a nutrient of concern
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: The Oxford Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pelvic floor impact questionnaire- short form 7 (PFIQ-7)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean radiation dose to Organs at Risk (OAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum radiation dose to Organs at Risk (OAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatique
Endpoint domain: Life impact
Endpoint subdomain: Fatigue